Академический Документы
Профессиональный Документы
Культура Документы
Triggers of asthma
Physical findings :
Altered mental status
Diaphoresis
Inability to speak
PEFR < 100 L / min.
Diagnostic Assessments to
Consider for Asthma
Disposition
"Secondary" Meds
Methylxanthines
Ketamine
Heliox
Halothane
Leukotriene inhibitors
May cause :
Laryngospasm
Hypertension
Hallucinations
Methotrexate
Cyclosporin
Colchicine
Acupuncture
Chiropractic
Homeopathy
Breathing techniques
Yoga
Airway Management in
Asthma
Endotracheal intubation should be required in <
5% of admitted pts.
Indications for ETT :
Altered mental status due to hypercarbia or hypoxia
Progressive resp. failure or resp. acidosis despite
maximal Rx
Base decision on clinical situation (not a particular
value of pCO2 or pO2 or pH)
Disadvantages :
May cause epistaxis
Requires smaller tube diameter than oral (so more airflow
resistance)
May predispose pt. to sinusitis later
Complications of Mechanical
Ventilation of the Asthmatic Patient
Barotrauma due to alveolar rupture
Pneumomediastinum, pneumothorax, or SQ emphysema
Should usually treat with chest tube
May need to reset ventilation parameters to decrease
end-inspiratory plateau pressure
Prolonged muscle weakness
Can be due to prolonged effect of paralytic agent used for
intubation (esp. if renal insufficiency)
May be partly due to steroid Rx
Can be a myopathic syndrome with increased muscle enzymes &
require ventilation for several weeks
Asthma
Lecture Summary
Chronic Obstructive
Pulmonary Disease (COPD)
Refers to triad of disease processes :
Asthma (airway reactivity)
Bronchitis (airway inflammation)
Emphysema (airway collapse)
All 3 coexist to some degree in same pt.
Definitions :
Chronic bronchitis = chronic cough with sputum
production for at least 3 months / yr. for at least 2 yrs.
Emphysema = enlargement of distal air passages due to
alveolar septal destruction (& obliteration of pulm. capillary
bed)
COPD Epidemiology
4th leading cause of death in U.S.
Leading cause of death in smokers > age
55
12.5 million in U.S. have chronic bronchitis
14 million in U.S. have emphysema
2nd most common cause of permanent
disability
Huge economic impact
Pathophysiologic Features of
COPD
airflow
lung volumes, hyperinflation
V/Q mismatch
Arterial hypoxemia & hypercarbia
Often intrinsic airway inflammation
Note typical inflammatory cells in
COPD are usually neutrophils,
whereas they are usually
eosinophils in asthma
Sequence of Pathophysiologic
Events with COPD
Parenchymal destruction continues
Distal air spaces enlarge
Loss of elastic recoil
Increases lung volumes when resp. rate
Expiratory time then
Hyperinflation results
Pathophysiologic Results of
Dynamic Hyperinflation in COPD
Inspiratory muscle dysfunction
Acts at stiffer portion of its volume pressure relationship
Muscle fibers forced from vertical to
horizontal position
Increased reliance on accessory muscle
fibers
Dyspnea
Tachypnea
Tachycardia
Ashen skin color or cyanosis
Diaphoresis
Accessory muscle use
Intercostal retractions
Rales / rhonchi / wheezes / decreased BS
Apprehension
Differential Dx of COPD
Exacerbation
CHF
Acute myocardial ischemia
Airway obstruction
Pneumonia
Pneumothorax
Pulmonary embolus
Pleural effusion
Acute aortic dissection
Allergic reaction
Dose
0.5 mg
1 to 2 mg (0.025 mg/kg)
0.2 to 1.0 mg